MediWound Ltd.’s $10 Million Shares Offering

Gornitzky represented Oppenheimer in the deal.MediWound Ltd., a biopharmaceutical company, executed a U.S. $10 million underwritten follow-on public offering of ordinary shares on Nasdaq. MediWound develops, manufactures and commercializes…